Performance of a no-pretreatment tacrolimus assay on the Dade Behring Dimension RxL clinical chemistry analyzer
- 4 June 2007
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 384 (1) , 48-51
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Immunosuppressive Drugs for Kidney TransplantationNew England Journal of Medicine, 2004
- IMx tacrolimus II assay: is it reliable at low blood concentrations? A comparison with tandem MS/MSClinical Biochemistry, 2002
- Tacrolimus is a class II low-solubility high-permeability drug: The effect of P-glycoprotein efflux on regional permeability of tacrolimus in ratsJournal of Pharmaceutical Sciences, 2002
- THE EFFECT OF GUT METABOLISM ON TACROLIMUS BIOAVAILABILITY IN RENALTRANSPLANT RECIPIENTS1,2Transplantation, 2001
- Failure of Traditional Trough Levels to Predict Tacrolimus ConcentrationsTherapeutic Drug Monitoring, 2001
- The pharmacokinetics and metabolic disposition of tacrolimus: A comparison across ethnic groupsClinical Pharmacology & Therapeutics, 2001
- Tacrolimus clearance is age-dependent within the pediatric populationBone Marrow Transplantation, 2000
- Therapeutic drug monitoring of cyclosporine and tacrolimusClinical Biochemistry, 1998
- Clinical Pharmacokinetics of TacrolimusClinical Pharmacokinetics, 1995
- Distribution and Protein Binding of FK506, a Potent Immunosuppressive Macrolide Lactone, in Human Blood and Its Uptake by ErythrocytesJournal of Pharmacy and Pharmacology, 1994